Alembic Pharmaceuticals Ltd Share Price
(APLLTD)
₹887.15▲0.24%
as on 04:01PM, 03 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 18.87 % |
3 Month Return | -15.97 % |
1 Year Return | -10.7 % |
Market Stats | |
Previous Close | ₹885.00 |
Open | ₹898.25 |
Volume | 2.57L |
Upper Circuit | ₹1,062.00 |
Lower Circuit | ₹708.00 |
Market Cap | ₹17,395.84Cr |
P/E Ratio
29.38
PEG Ratio
734.56
Market Cap
₹17,395.84 Cr
P/B Ratio
3.93
EPS
31.33
Dividend Yield
1.12
Sector
Pharmaceuticals
ROE
14.3
Funds | Holdings | Prev. 5M |
---|---|---|
![]() | 1.77% | |
![]() | 1.39% | |
![]() | 0.51% | |
![]() | 3.59% | |
![]() | 0.71% |
based on 12 analysts
41.67%
Buy
41.67%
Hold
16.67%
Sell
Based on 12 analysts offering long term price targets for Alembic Pharmaceuticals Ltd. An average target of ₹1050.92
Source: S&P Global Market Intelligence
Alembic Pharmaceuticals Ltd price forecast by 12 analysts
Upside of18.75%
High
₹1411
Target
₹1050.92
Low
₹895
Alembic Pharmaceuticals Ltd target price ₹1050.92, a slight upside of 18.75% compared to current price of ₹887.15. According to 12 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Alembic Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:31.00%
Forecast
Actual
Including amortisation and stock based compensations
Alembic Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:59.75%
Forecast
Actual
Source: S&P Global Market Intelligence
Alembic Partners with Amlan for Poultry Solutions - 25 Mar, 2025
Alembic Pharma's API Facility Passes USFDA Inspection - 22 Mar, 2025
Alembic Pharmaceuticals Expands with US Subsidiary - 18 Mar, 2025
Alembic Pharma Faces FDA Observation Amid Profit Decline - 08 Mar, 2025
Alembic Pharma's FDA Inspection Ends with Observation - 07 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 8.90% to 8.96% in Dec 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 3.94% to 4.17% in Dec 2024 quarter
Revenue Rich
Revenue is up for the last 4 quarters, 1.52K Cr → 1.70K Cr (in ₹), with an average increase of 3.7% per quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 126.6% return, outperforming this stock by 109.5%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 53.8% return, outperforming this stock by 64.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.61% of holdings in Dec 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 153.41 Cr → 138.42 Cr (in ₹), with an average decrease of 9.8% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 10.39% to 10.16% in Dec 2024 quarter
Price Dip
In the last 7 days, APLLTD stock has moved down by -5.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 69.61% | 0.00 | |
Foreign Institutions | 4.17% | 5.77 | |
Mutual Funds | 8.96% | 0.73 | |
Retail Investors | 10.16% | ||
Others | 7.09% |
Alembic Pharmaceuticals Ltd in the last 5 years
Lowest (11.53x)
March 23, 2020
Today (29.38x)
April 2, 2025
Industry (52.26x)
April 2, 2025
Highest (53.41x)
January 3, 2023
Alembic Pharmaceuticals Ltd’s net profit fell -23.29% since last year same period to ₹138.42Cr in the Q3 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -9.77% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Alembic Pharmaceuticals Ltd has declared dividend of ₹11 - translating a dividend yield of 1.24%.
Read More about DividendsBearish
Neutral
Bullish
Alembic Pharmaceuticals Ltd is currently in a Neutral trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹17,395.84 Cr | 13.02% | 0.55 | ₹615 Cr | ₹6,228 Cr | |
BUY | ₹13,532.31 Cr | -2.34% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
BUY | ₹67,842.90 Cr | 40.56% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
HOLD | ₹89,670.54 Cr | 44.91% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
BUY | ₹62,774.41 Cr | 17.37% | 0.53 | NA | NA |
Organisation | Alembic Pharmaceuticals Ltd |
Headquarters | Vadodara |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Alembic Pharmaceuticals Ltd share price today stands at ₹887.15, Open: ₹898.25, Previous Close: ₹885, High: ₹922.85, Low: ₹873.15, 52 Week High: ₹1303.9, 52 Week Low: ₹725.2.
Today's traded volume of Alembic Pharmaceuticals Ltd(APLLTD) is 2.57L.
Today's market capitalisation of Alembic Pharmaceuticals Ltd(APLLTD) is ₹17395.84Cr.
Alembic Pharmaceuticals Ltd (APLLTD) share price is ₹887.15. It is down -31.96% from its 52 Week High price of ₹1303.9
Alembic Pharmaceuticals Ltd (APLLTD) share price is ₹887.15. It is up 22.33% from its 52 Week Low price of ₹725.2